A graduate of the Albert Einstein College of Medicine, Dr. Erol Onel spent more than seven years as the vice president of clinical research and medical information for Pacira Pharmaceuticals, Inc. He currently serves as vice president of Heron Therapeutics, working as part of a team committed to securing approval for a long-acting non-opioid drug. Additionally, Dr. Erol Onel has served on the board of directors and chaired the annual meeting for the American Society of Andrology.
Established in 1975, the American Society of Andrology (ASA) comprises 600 professionals in the field of male reproduction, gynecology/obstetrics, urology, and reproductive technologies. The organization’s Women in Andrology (WIA) division focuses specifically on contributions women have made to the field, and strives to support women ASA members through mentoring and networking. To that end, WIA hosts an annual luncheon that honors various members with awards and recognition, as well as announcing significant achievements in the field of andrology. The luncheon also includes presentations on career development and scientific topics.